tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
Advertisement

Ascentage Pharma Group International (6855) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascentage Pharma Group International
HK$78.90
HK$28.67B
136.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$17.37
HK$25.96B
205.82%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$33.58
HK$49.71B
215.01%
1 Buy
0 Hold
1 Sell
Hold
Everest Medicines Ltd.
HK$60.20
HK$20.88B
157.86%
0 Buy
1 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$13.85
HK$35.95B
35.88
127.36%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$81.10
HK$44.08B
49.52
243.94%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6855
Ascentage Pharma Group International
77.55
44.10
131.84%
HK:9969
InnoCare Pharma Ltd.
16.82
11.05
191.51%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
33.58
22.92
215.01%
HK:1952
Everest Medicines Ltd.
59.05
35.55
151.28%
HK:2096
Simcere Pharmaceutical Group Limited
13.46
7.41
122.48%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
79.45
56.30
243.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis